The emerging treatment of the medication represents a exciting advance in the handling of the condition. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide933776.uzblog.net/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-55680008